BioNexus Gene Lab BGLC
NASDAQ BGLC
$1.27 -0.03 (-2.31%)
At close: Sep 29, 2026 · 4:00 PM EDT

BioNexus Gene Lab (BGLC) EV to EBIT (2021 - 2022)

Updated

BioNexus Gene Lab's (BGLC) EV to EBIT stood at 5607.72 in Q3 2022, compared with 235.21 a year earlier.

Analysis

BioNexus Gene Lab (BGLC) EV to EBIT (2021 - 2022) Analysis & Trends

On a TTM basis, BioNexus Gene Lab's EV to EBIT came in at 5444.76 as of Sep 30, 2022; for FY2021, it came in at 343.39.

  • Per Business Quant, the preceding three quarters came in at 418.11 (Q2 2022), 388.74 (Q1 2022) and 343.40 (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 W.W. Grainger 59.11 Bn 57.09 Bn 1.98 Bn
2 Fastenal 57.94 Bn 56.86 Bn 1.06 Bn
3 Ferguson Enterprises 44.13 Bn 41.35 Bn 2.32 Bn
4 Sunbelt Rentals Holdings 30.69 Bn 30.57 Bn 1.25 Bn
5 Reliance 20.00 Bn 19.04 Bn 1.30 Bn
6 Wesco International 17.78 Bn 15.09 Bn 1.46 Bn
7 Applied Industrial Technologies 12.42 Bn 12.29 Bn 411.22 Mn
8 Watsco 11.14 Bn 9.30 Bn 578.93 Mn
9 Avantor 10.34 Bn 9.14 Bn 537.00 Mn
10 BioNexus Gene Lab 2.41 Mn -4.96 Mn 12,982.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 5,607.72
Jun 30, 2022 418.11
Mar 31, 2022 388.74
Dec 31, 2021 343.40
Sep 30, 2021 235.21
Jun 30, 2021 272.78
Mar 31, 2021 658.32
API Access

BioNexus Gene Lab EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=BGLC&period=max&api_key=YOUR_API_KEY